Naoki Sasahira

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study

Michael S. Lee, Baek‐Yeol Ryoo, Chih‐Hung Hsu et al. · The Lancet Oncology · 2020 · 555 citations

Phase 1B, Hepatology, Medicine +8

Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment

K. Hirano, Minoru Tada, Hiroyuki Isayama et al. · Gut · 2007 · 280 citations · Full text

Detection of common bile duct stones: comparison between endoscopic ultrasonography, magnetic resonance cholangiography, and helical-computed-tomographic cholangiography

Shintaro Kondo, Hiroyuki Isayama, Masaaki Akahane et al. · European Journal of Radiology · 2004 · 254 citations

Eus-guided Gallbladder Drainage, Hepatology, Medical Imaging +11

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 254 citations · Full text

Measurement of radial and axial forces of biliary self-expandable metallic stents

Hiroyuki Isayama, Yousuke Nakai, Yoshihide Toyokawa et al. · Gastrointestinal Endoscopy · 2009 · 230 citations

Engineering, Mechanical Engineering, Surgery +2